September 2015 | Mediq |
Healthcare |
FERBER & CO. advised Mediq on the acquisition of Reininger Group. |
 |
|
March 2023 |
FR L'Osteria SE and its shareholders |
Consumer Goods and Retail |
FERBER & CO. advised FR L'Osteria SE and its shareholders on the sale of a majority stake to McWin Partners.
|
 |
January 2023 |
Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm on the acquisition of Arkopharma SE from Montagu Private Equity LLP. |
 |
December 2022 |
Apurano Pharmaceuticals |
Healthcare |
FERBER & CO. advised Apurano Pharmaceuticals on the realignment of its shareholder base including expansion funding round. |
 |
February 2022 |
Vitafy Brands and its shareholders |
Healthcare |
FERBER & CO. advised Vitafy Brands and its shareholders on the merger with EVP Group. |
 |
January 2022 |
Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm on the acquisition of C3 - Cannabinoid Compound Company GmbH from Canopy Growth Corporation. |
 |
January 2022 |
Dermazentrum and its founder |
Healthcare |
FERBER & Co. advised Dermazentrum and its founder on the sale of a majority ownership stake in an Owners Buy-out to Halder. |
 |
June 2021 |
Wellster Healthtech |
Healthcare |
FERBER & CO. advised and supported Wellster Healthtech in its funding round on the successful completion of a USD 40m private placement led by a group of investors. |
 |
February 2021 |
Shareholders of teamtechnik Maschinen und Anlagen GmbH |
Industrials and Capital Goods |
FERBER & CO. advised the shareholders of teamtechnik Maschinen und Anlagen GmbH on the sale of a 75% majority interest to Dürr group. |
 |
December 2020 |
Permira |
Healthcare |
FERBER & CO. advised Permira on the aquisition of Neuraxpharm from Apax Partners. |
 |
December 2020 |
Oakley Capital |
Healthcare |
FERBER & CO. advised Oakley Capital on the acquisition of WindStar Medical GmbH from ProSiebenSat.1 majority-owned NuCom Group. |
 |